Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	38.08	65.06	90.03	139.07	123.44	96.58
Short-Term Investments	205.25	281.34	408.17	214	564.83	480.29
Cash & Short-Term Investments	243.33	346.4	498.2	353.06	688.27	576.87
Cash Growth	-34.44%	-30.47%	41.11%	-48.70%	19.31%	249.58%
Accounts Receivable	40.81	37.97	40.06	17.41	10.05	12.68
Other Receivables	1.3	1	0.8	1.4	2.5	2.2
Receivables	42.11	38.97	40.86	18.81	12.55	14.88
Inventory	11.96	14.45	14.45	19.26	14.06	9.07
Prepaid Expenses	10.95	10.37	8.64	11.62	12.04	11.38
Other Current Assets	-	-	-	-	-	0.5
Total Current Assets	308.35	410.19	562.15	402.75	726.91	612.69
Property, Plant & Equipment	97.84	120.32	164.21	172.94	139.04	23.75
Long-Term Investments	23.87	-	-	217.15	118.53	105.44
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	3.85	5.13	6.83	8.53	10.23	11.93
Other Long-Term Assets	5.63	6.52	4.46	3.01	2.74	39.53
Total Assets	558.51	661.13	856.62	923.34	1,116	912.3
Accounts Payable	7.35	7.72	8.08	3.31	3.24	4.45
Accrued Expenses	18.4	20.39	24.1	22.2	18.92	9.88
Current Portion of Leases	10.02	9.38	9.23	5.06	3.53	-
Current Income Taxes Payable	-	0.06	0.19	0.39	0.37	0.16
Current Unearned Revenue	51.86	48.63	64.12	80.46	73.32	60.99
Other Current Liabilities	-	1.84	4.07	2.39	5.82	2.83
Total Current Liabilities	87.63	88.02	109.79	113.81	105.2	78.31
Long-Term Debt	132.7	130.66	125.36	-	-	-
Long-Term Leases	81.8	89.39	98.77	106.69	104.33	36.61
Long-Term Unearned Revenue	32.78	44.79	58.6	98.75	163.62	219.33
Other Long-Term Liabilities	0.02	-	-	-	-	7.01
Total Liabilities	334.93	352.86	392.52	319.24	373.15	341.26
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,493	1,453	1,387	1,324	1,254	935.83
Retained Earnings	-1,270	-1,144	-919.08	-718.89	-511.61	-365.48
Comprehensive Income & Other	0.5	0.22	-4.12	-1.14	0.89	0.67
Total Common Equity	223.77	308.4	464.17	603.99	743.27	571.04
Minority Interest	-0.2	-0.12	-0.07	0.11	-	-
Shareholders' Equity	223.57	308.28	464.1	604.1	743.27	571.04
Total Liabilities & Equity	558.51	661.13	856.62	923.34	1,116	912.3
Total Debt	224.53	229.43	233.36	111.74	107.86	36.61
Net Cash (Debt)	42.67	116.97	264.83	458.47	698.93	645.69
Net Cash Growth	-69.50%	-55.83%	-42.23%	-34.40%	8.25%	291.29%
Net Cash Per Share	0.29	0.81	1.86	3.27	5.33	9.34
Filing Date Shares Outstanding	147.58	145.09	143.23	141.58	139.22	126.32
Total Common Shares Outstanding	147.56	145.08	143.11	141.39	137.65	125.24
Working Capital	220.72	322.17	452.36	288.94	621.72	534.38
Book Value Per Share	1.52	2.13	3.24	4.27	5.40	4.56
Tangible Book Value	100.95	184.3	338.37	476.49	614.07	440.14
Tangible Book Value Per Share	0.68	1.27	2.36	3.37	4.46	3.51
Machinery	-	61.36	56.7	48.88	34.08	24.79
Construction In Progress	-	3.41	7.63	5.66	7.19	1.85
Leasehold Improvements	-	74.73	72.4	65.96	21.95	14.72

Source: S&P Capital IQ. Standard template. Financial Sources.